Born in 1981, Şiran Keske graduated from Hacettepe University School of Medicine (Ankara, Turkey) in 2005. In 2011, he completed his residency in Infectious Diseases and Clinical Microbiology at Ankara Research and Training Hospital in Turkey. He studied in Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine in 2010.
Since 2016, he has worked at the American Hospital in Istanbul. He received the Young Investigator award from the Turkish Society of Clinical Microbiology and Infectious Diseases (KLİMİK) in 2018 and became an Associate Professor in 2020. He has also been working in Koç University, School of Medicine, department of Infectious Diseases and Clinical Microbiology since 2021.
Şiran Keske is editorial board member of “Balkan Medical Journal” and “Infectious Diseases & Clinical Microbiology” (IDCM) journal. He worked as a panel member in COVID-19 and he has been working as a panel member in Influenza guideline projects for ESCMID (European Society of Clinical Microbiology and Infectious Diseases). He is chair of “Study group for Healthcare Associated Infections” under Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK) since 2022.
His main research areas include antimicrobial stewardship (AMS), respiratory viral infections, healthcare-associated infections, and emerging infections, such as Crimean Congo Hemorrhagic Fever. He mainly work on the implementation of multiplexed panel tests and clinical pathways as a part of AMS programs within his institution. He is faculty member of KUISCID (Koç University İşbank Center for Infectious Diseases), a research center equipped with a BSL-3 laboratory. As part of multidisciplinary team comprising clinical microbiologists, virologists and infectious diseases clinicians, he has contributed to and lead several studies addressing MDR gram negative infections, carbapenemase positive Klebsiella pneumonia infections, viral culture-based SARS CoV-2 shedding. During the COVID19 pandemics, he visited Kosova and Bosnia-Herzegovina with his colleagues to share expertise on the management of COVID19.